Smith Andrew Alasdair Insider Trading -- Recent SEC Form 4 Transactions

Smith Andrew Alasdair (CIK 1309614) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-08). Recent activity: Buy MDCX (735,294 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-09-08Medicus Pharma Ltd. (MDCX)Chief Operating OfficerBuy735,294$125,368

来源:SEC Form 4 申报文件 · 截至 2026-09-08